Neuropsychological sequelae of non-central nervous system cancer and cancer therapy (Q37139476)

18 August 2017

1 reference

title

Neuropsychological sequelae of non-central nervous system cancer and cancer therapy (English)

1 reference

18 August 2017

1 reference

nervous system cancer

1 reference

0 references

Jeffrey S Wefel

1

1 reference

PubMed ID

18415683

18 August 2017

Mariana E Witgert

series ordinal

2

1 reference

PubMed ID

18415683

18 August 2017

Christina A Meyers

series ordinal

3

1 reference

18 August 2017

16 April 2008

1 reference

18 August 2017

Neuropsychology Review

1 reference

18 August 2017

18

1 reference

18 August 2017

121-131

1 reference

18 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11065-008-9058-x

18 August 2017

0 references

cites work

Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury.

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Reproductive and hormonal sequelae of chemotherapy in women. Premature menopause and impaired fertility can result, effects that are especially disturbing to young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

MTX-induced white matter changes are associated with polymorphisms of methionine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Persistent neurotoxicity of systemically administered interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Alzheimer disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-008-9058-X

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

21 January 2018

1 reference

12 December 2020

The effects of oestrogens and anti-oestrogens on cognition

1 reference

12 December 2020

Neurological complications of radiotherapy and chemotherapy

1 reference

12 December 2020

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study

1 reference

12 December 2020

Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors.

1 reference

12 December 2020

Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.

1 reference

12 December 2020

Manic episodes in two patients treated with interferon alpha

1 reference

12 December 2020

Psychologic and neuropsychologic impact of autologous bone marrow transplantation.

1 reference

12 December 2020

Intermediate dose 5-fluorouracil-induced encephalopathy.

1 reference

12 December 2020

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

1 reference

12 December 2020

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

1 reference

12 December 2020

The effects of hormone therapy on cognition in breast cancer

1 reference

12 December 2020

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

1 reference

12 December 2020

No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors.

1 reference

12 December 2020

Androgen deprivation and cognition in prostate cancer

1 reference

12 December 2020

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

1 reference

12 December 2020

Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines.

1 reference

12 December 2020

'Chemobrain' in breast carcinoma?: a prologue

1 reference

12 December 2020

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

1 reference

12 December 2020

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

1 reference

12 December 2020

An assessment of agonist/antagonist effects of tamoxifen in the female mouse brain.

1 reference

12 December 2020

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity in adult hematologic malignancies

1 reference

12 December 2020

1 reference

12 December 2020

Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules

1 reference

12 December 2020

Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL.

1 reference

12 December 2020

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

1 reference

12 December 2020

Side effects of adjuvant treatment of breast cancer

1 reference

12 December 2020

Neurological function during long-term therapy with recombinant interferon alpha.

1 reference

12 December 2020

Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant

1 reference

12 December 2020

A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities

1 reference

12 December 2020

Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments

1 reference

12 December 2020

Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia

1 reference

12 December 2020

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

1 reference

12 December 2020

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

12 December 2020

Neurologic complications of cancer chemotherapy

1 reference

12 December 2020

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

1 reference

12 December 2020

Exposure to anthracyclines during childhood causes cardiac injury

1 reference

12 December 2020

13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice

1 reference

12 December 2020

Neurobehavioral effects of interferon therapy

1 reference

12 December 2020

Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.

1 reference

12 December 2020

Chemotherapy-induced ovarian failure: manifestations and management

1 reference

12 December 2020

Paraneoplastic syndromes of the nervous system

1 reference

12 December 2020

Late neurocognitive sequelae in survivors of brain tumours in childhood

1 reference

12 December 2020

Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy

1 reference

12 December 2020

Historical overview of biologic response modifiers

1 reference

12 December 2020

Pharmacogenetics of capecitabine in advanced breast cancer patients

1 reference

12 December 2020

Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity

1 reference

12 December 2020

Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity

1 reference

12 December 2020

Interferon-mediated fatigue

1 reference

12 December 2020

A cytokine-based neuroimmunologic mechanism of cancer-related symptoms

1 reference

12 December 2020

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

1 reference

12 December 2020

Effects of interferon alpha on performance in man: a preliminary report.

1 reference

12 December 2020

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes

1 reference

12 December 2020

Cancer as a risk factor for long-term cognitive deficits and dementia

1 reference

12 December 2020

Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible.

1 reference

12 December 2020

Cancer as a risk factor for dementia: a house built on shifting sand.

1 reference

12 December 2020

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

12 December 2020

Paroxetine for the prevention of depression induced by high-dose interferon alfa

1 reference

12 December 2020

Hippocampal volumes smaller in chemotherapy patients.

1 reference

12 December 2020

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

1 reference

12 December 2020

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

1 reference

12 December 2020

Glutathione S-transferase polymorphisms and survival in primary malignant glioma

1 reference

12 December 2020

Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation.

1 reference

12 December 2020

ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy

1 reference

12 December 2020

Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain

1 reference

12 December 2020

Cognitive deficits in adult patients with brain tumours

1 reference

12 December 2020

The Effects of Combined Androgen Blockade on Cognitive Function During the First Cycle of Intermittent Androgen Suppression in Patients With Prostate Cancer

1 reference

12 December 2020

Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer

1 reference

12 December 2020

Cognitive deficits in patients with small cell lung cancer before and after chemotherapy

1 reference

12 December 2020

Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.

1 reference

12 December 2020

Anemia in the oncology patient: cognitive function and cancer

1 reference

12 December 2020

Associations between serum testosterone fall and cognitive function in prostate cancer patients

1 reference

12 December 2020

Treatment of neurotoxic side effects of interferon-alpha with naltrexone

1 reference

12 December 2020

Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment.

1 reference

12 December 2020

Interferon alpha (IFNalpha) and psychiatric syndromes: a review

1 reference

12 December 2020

Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives

1 reference

12 December 2020

Bupropion for treatment of interferon-induced depression

1 reference

12 December 2020

Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.

1 reference

12 December 2020

Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.

1 reference

12 December 2020

Potential mechanisms for chemotherapy-induced impairments in cognitive function

1 reference

12 December 2020

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

1 reference

12 December 2020

White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.

1 reference

12 December 2020

Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.

1 reference

12 December 2020

Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative study.

1 reference

12 December 2020

Neurocognitive outcomes in survivors of childhood cancer

1 reference

12 December 2020

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

12 December 2020

Neuropsychologic impairment in adult bone marrow transplant candidates

1 reference

12 December 2020

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

1 reference

12 December 2020

Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression

1 reference

12 December 2020

Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation

1 reference

12 December 2020

The distribution and metabolism of 14C-labelled tamoxifen in spayed female mice

1 reference

12 December 2020

One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.

1 reference

12 December 2020

Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

1 reference

12 December 2020

Estradiol and cognition during androgen deprivation in men with prostate carcinoma

1 reference

12 December 2020

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.

1 reference

12 December 2020

Cognitive function and quality of life in interferon therapy for melanoma

1 reference

12 December 2020

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

12 December 2020

Delirium in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

Tamoxifen and toremifene impair retrieval, but not acquisition, of spatial information processing in mice

1 reference

12 December 2020

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

1 reference

12 December 2020

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

1 reference

12 December 2020

Biological response modifiers

1 reference

12 December 2020

Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia

1 reference

12 December 2020

Mood and cognitive side effects of interferon-alpha therapy

1 reference

12 December 2020

Hippocampal brain amines in methotrexate-induced learning and memory deficit

1 reference

12 December 2020

Candidate mechanisms for chemotherapy-induced cognitive changes

1 reference

12 December 2020

Neurotoxicity of CI-980, a novel mitotic inhibitor

1 reference

12 December 2020

10.1007/S11065-008-9058-X

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18415683